The Michelin and Wabco-backed in-car telematics technology developer has now raised at least $265m, following a $90m investment by TPG Sixth Street Partners.
Month: September 2019
Elan chips in for $290m Vertex fund
Elan Microelectronics has contributed to a $290m fund raised by Vertex Ventures that has so far invested 10% of its capital in markets including Southeast Asia.
Satsuma avoids IPO headache to go public
Shin Nippon’s migraine treatment spinoff, Satsuma Pharmaceuticals, floated above its range to raise $82.5m in an offering that follows $86m of funding.
Pomelo pins down $52m series C
Returning investor Central Group has contributed to a round that boosted fashion e-commerce platform Pomelo’s overall funding to more than $83m.
Akeneo acts to raise $46m
Brand standardisation platform developer Akeneo took its total funding past the $60m mark with a round featuring existing backer Salesforce Ventures.
Analysis: Life science exits maintain healthy pulse
September started out with news on several life sciences companies about to go public as well as a large acquisition deal of another one of them. This space enjoyed a great number of exits last year and the trend appears on a path to be continued through 2019.
Corporates take Voyage to $31m series B
Chevron Technology Ventures and existing backer InMotion Ventures contributed to a round that increased the autonomous taxi developer’s total funding to $52m.
ScyllaDB files away $25m
The database technology developer increased its overall funding to $60m in a round featuring existing investor Qualcomm Ventures.
Sinar Mas Land prepares ground for accelerator
Sinar Mas Land plans to form a property technology-focused incubator with accelerators Digitaraya and GK Plug and Play that will kick off early next year.
Corporate venturing deal net: 9-13 September 2019
Each Friday the Global Corporate Venturing Deal Net rounds up the week’s smaller deals and tracks the emerging companies accessing corporate funds.
Neighborhood Goods bags up $11m
CAA Ventures-backed department store Neighborhood Goods has added $11m of series A capital to bring its total funding to $25.5m.
GlaxoSmithKline settles Sitari purchase
GSK’s co-investment partnership with Avalon Ventures has borne fruit with the acquisition of celiac treatment developer Sitari Pharmaceuticals.
TrialCard picks Mango Health for acquisition
Express Scripts is set to exit Mango Health having made a strategic investment in the health management app developer two years ago.
Replica rises with $11m
Replica, an urban planning technology startup spun off from Alphabet’s Sidewalk Labs subsidiary, has raised $11m in series A funding.